No Data
Aidite (301580.SZ): As of the end of 2023, the proportion of the R&D team reached 14.64%, and R&D innovation investment has been increasing year by year.
Gelonghui, Oct. 14th - Edith (301580.SZ) stated on the investor interaction platform that the company has been shortlisted for the sixth batch of national specialized, special, and new "little giant" enterprise public announcement list, and was publicly announced in early September 2024. The company focuses on casting specialty, enhancing industrial matching, and winning the market through innovation. By the end of 2023, the research and development team accounted for 14.64%, with annual increases in research and development innovation investment. After more than 10 years of technological accumulation and product iteration, starting from 2021, the company has successively won the first prize of the Beijing Science and Technology Award, the Geneva Invention Gold Award, and other honors, and has obtained the national key research and development program "diagnosis".
Individual Investors Who Hold 35% of Aidite (Qinhuangdao) Technology Co., Ltd. (SZSE:301580) Gained 27%, Insiders Profited as Well
Admate (301580.SZ): zirconia material is currently the preferred material for clinical oral restoration due to its excellent performance.
On September 29th, Gelonghui reported that Aidit (301580.SZ) stated at an investor relations event that zirconia material, due to its excellent performance, is currently the preferred material for clinical oral restoration.
Editt: 2024 Semi-Annual Report
Editt: 2024 Semi-Annual Report Summary
Ai Dite (301580.SZ): The net income in the first half of the year was 76.7894 million yuan, a year-on-year growth of 21.41%.
On August 29, Gelunhui reported its semi-annual report for 2024, with a total operating income of 0.414 billion yuan, a year-on-year increase of 16.74%; a net income attributable to the company's shareholders of 76.7894 million yuan, an increase of 21.41% year-on-year; a net income attributable to the company's shareholders after deducting non-recurring gains and losses of 77.2372 million yuan, an increase of 36.46% year-on-year; and an eps of 1.35 yuan.
No Data
No Data